Fulcrum Therapeutics

Yahoo Finance • last year

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced... Full story

Yahoo Finance • last year

Fulcrum Therapeutics to Participate at Upcoming November Investor Conferences

CAMBRIDGE, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined ra... Full story

Yahoo Finance • last year

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2023

― Completed enrollment in the Phase 3 REACH trial of losmapimod in facioscapulohumeral muscular dystrophy (FSHD); expect to report topline data in the fourth quarter of 2024 ― ― U.S. Food and Drug Administration (FDA) lifted clinical hold... Full story

Yahoo Finance • last year

Fulcrum Therapeutics to Host Third Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023, at 8:00 a.m. ET

CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with geneti... Full story

Yahoo Finance • last year

Fulcrum Therapeutics to Participate at the Cantor Fitzgerald Global Healthcare Conference

CAMBRIDGE, Mass., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announce... Full story

Yahoo Finance • last year

Lifshitz Law PLLC Announces Investigations of Fulcrum Therapeutics, Inc. (NASDAQ: FULC), Horizon Bancorp, Inc. (NASDAQ: HBNC), Wheels Up Experience, Inc. (NYSE: UP), and Nutanix, Inc. (NASDAQ: NTNX)

NEW YORK, Sept. 09, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegation... Full story

Yahoo Finance • last year

FDA Lifts Clinical Hold on Fulcrum Therapeutics’ FTX-6058 for Sickle Cell Disease

CAMBRIDGE, Mass., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced... Full story

Yahoo Finance • last year

Fulcrum Therapeutics Signs Exclusive Global License Agreement in Rare Hematology

CAMBRIDGE, Mass., July 10, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (NASDAQ: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced... Full story

Yahoo Finance • last year

DEADLINE ALERT for FULC, TDS, SPR, IEP: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

BENSALEM, Pa., June 27, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story

Yahoo Finance • last year

FULC LAWSUIT ALERT: Levi & Korsinsky Notifies Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fulcrum Therapeutics, Inc. ("Fulcrum" or the "Company") (NASDAQ: FULC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to... Full story

Yahoo Finance • last year

FULC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 27, 2023 in the Class Action Filed on Behalf of Fulcrum Therapeutics, Inc. Shareholders

NEW YORK, June 26, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) alleging that the Company violated federal secur... Full story

Yahoo Finance • last year

DEADLINE ALERT for ADDYY/ADDDF, FULC, TDS, and SPR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, June 26, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story

Yahoo Finance • last year

Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fulcrum Therapeutics, Inc. (FULC) Investors of Class Action and to Actively Participate

NEW YORK, June 26, 2023 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fulcrum Therapeutics, Inc. (“Fulcrum” or the “Company”) (NASDAQ: F... Full story

Yahoo Finance • last year

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulcrum Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – FULC

NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulcrum Therapeutics, Inc. (“Fulcrum” or the “Company”) (NASDAQ: FULC), and certain officers.   The class action, file... Full story

Yahoo Finance • last year

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Edgio, Fulcrum, adidas, and Spirit AeroSystems and Encourages Investors to Contact the Firm

NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Edgio, Inc. (NASDAQ: EGIO... Full story

Yahoo Finance • 2 years ago

FULC FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important June 27 Deadline in Securities Class Action – FULC

NEW YORK, June 24, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulcrum Therapeutics Inc. (NASDAQ: FULC) between March 3, 2022 and March 8, 2023, both dates inclusiv... Full story

Yahoo Finance • 2 years ago

FULC LAWSUIT ALERT: Levi & Korsinsky Notifies Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fulcrum Therapeutics, Inc. ("Fulcrum" or the "Company") (NASDAQ: FULC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to... Full story

Yahoo Finance • 2 years ago

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulcrum Therapeutics, Inc. (FULC)

LOS ANGELES, June 22, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 27, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or... Full story

Yahoo Finance • 2 years ago

FULCRUM THERAPEUTICS, INC.: Please contact the Portnoy Law Firm to recover your losses; June 27, 2023 deadline

LOS ANGELES, June 22, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fulcrum Therapeutics, Inc. (“Fulcrum” or the “Company”) (NASDAQ: FULC). investors that a lawsuit filed on behalf of investors that purchased Fulcrum securities b... Full story

Yahoo Finance • 2 years ago

Lifshitz Law PLLC Announces Investigations of Alphabet Inc. (NASDAQ: GOOG), Spirit AeroSys-tems Holdings, Inc. (NYSE: SPR), Telephone and Data Systems, Inc. (NYSE: TDS), and Fulcrum Therapeutics, Inc. (NASDAQ: FULC)

NEW YORK, June 22, 2023 (GLOBE NEWSWIRE) -- Alphabet Inc. (NASDAQ: GOOG) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Com... Full story